Shockwave Intravascular Lithotripsy FDA Approved to Treat Advanced Heart Disease Transformative Technology Now Available for Calcified Coronary Plaque
February 16, 2021 07:00 ET | Source: Shockwave Medical, Inc. Shockwave Medical, Inc. Santa Clara, California, UNITED STATES
SANTA CLARA, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the company’s sonic pressure wave therapy received Pre-Market Approval for severely calcified coronary artery disease from the U.S. Food and Drug Administration (FDA). The innovative technology, which was granted Breakthrough Device designation by the FDA, is a novel application of lithotripsy, an approach that has been used for decades to safely break up kidney stones. With this approval, IVL is now commercially av
February 16, 2021 PET scans demonstrate that middle-aged individuals with early signs of cardiovascular disease also have reduced brain metabolism, according to researchers from Spain. The findings indicate that the early stages of Alzheimer s disease could begin years before dementia occurs.
Researchers with the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid used PET to examine over 500 individuals participating in the Progression of Early Subclinical Atherosclerosis (PESA) project. Directed by CNIC general director Dr. Valentin Fuster, PhD, the PESA study is following over 4,000 employees from Banco Santander in Spain to identify lifestyle and other risk factors that lead to atherosclerotic diseases.
Coronavirus update: A big drop in new cases, CDC says to avoid pain meds before getting vaccinated
Cuomo pushes back against cover-up accusations over nursing home deaths 02/16/2021
Total U.S. confirmed cases: 27,703,142 (27,505,950)
Total U.S. deaths: 486,520 (482,956)
Total global cases: 109,285,411 (108,682,468)
Total global deaths: 2,411,745 (2,398,085)
New cases fall to lowest level since October
All across the country, doctors are reporting declines in new cases of the coronavirus (COVID-19). On Monday, the number of new cases of the virus fell to 53,000. That’s the smallest number of new cases since October.
California, which has been grappling with a surge in new cases and a record number of hospitalizations, reported its lowest daily case increase since early November. But health officials point out that it’s much too early to breathe a sigh of relief.
email article
Links between cardiovascular disease and cognitive decline may begin in midlife before the first clinical symptoms of either condition appear, cross-sectional data from a cohort study suggested.
Middle-age cardiovascular risk largely driven by hypertension was associated with brain hypometabolism, an imaging marker of neurodegeneration, according to Valentin Fuster, MD, PhD, of Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid, Spain, and Mount Sinai Hospital in New York City, and colleagues.
Subclinical carotid plaque burden also was tied to reduced brain metabolism independent of diabetes, hypertension, dyslipidemia, and smoking, they reported in the When brain metabolism declines, the brain s ability to handle adverse events can be compromised. Depending on the brain area affected, this can lead to a range of distinct problems, co-author Marta Cortes-Canteli, PhD, also of CNIC, said in a statement.